Insight Molecular Diagnostics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Insight Molecular Diagnostics Inc 's ROA in the second quarter of 2026?
Insight Molecular Diagnostics Inc recorded a cumulative net loss of $-49 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -144.38%.

However, within the Healthcare sector 801 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4329, from total ROA ranking in the first quarter of 2026 at 4985.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-41.72 %	-33.02 %	-44.59 %	-37.43 %	-32.39 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-49	-48	-50	-70	-73
Return On Assets (TTM)	-144.38 %	-121.25 %	-113.01 %	-142.91 %	-130.77 %
IMDX's Total Ranking	# 4329	# 4985	# 4509	# 4558	# 4573
Total Assets (TTM) in million	29	40	23	44	51
Seq. Total Assets Change	-27.17 %	76.22 %	-47.79 %	-13.03 %	-16.31 %
Seq. Net Income Change	-	-	-	-	-

IMDX's 5 Years Annual ROA >> Back to IMDX Management Effectiveness >> Compare IMDX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 14
Sector	# 802
Overall	# 4344

Return On Assets Statistics
High	Average	Low
-26.03 %	-83.23 %	-149.66 %
(Sep 30 2021)		(Dec 31 2017)

Financial Statements
Insight Molecular Diagnostics Inc 's Assets	$ 29 million	IMDX's Balance sheet
Insight Molecular Diagnostics Inc 's Income	$ -11 million	Quarterly IMDX's Income Statement
IMDX's Income by Division		See IMDX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-30.72 %	-59.77 %	-12.88 %	-37.27 %	240.66 %
Total Assets in million	24	35	87	100	160
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-50	-61	-29	-73	-64
Annual Return On Assets	-206.63 %	-173.67 %	-32.94 %	-73.36 %	-40.17 %

IMDX's 5 Years Annual ROA >> Back to IMDX Management Effectiveness >> Compare IMDX ROA to its Competitors

More Return On Assets Ratios
IMDX's' Return on Assets at Yahoo Finance
In Vitro & In Vivo Diagnostic Substances Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IMDX's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IMDX's Competitors
Subscribers only: Roa for Insight Molecular Diagnostics Inc 's Suppliers
Subscribers only: Return On Assets for IMDX's Customers

You may also want to know
IMDX's Roi	IMDX's Inventory Turnover Ratio	IMDX's Growth Rates	IMDX's Dividend Comparisons
	IMDX's Profitability Ratios	IMDX's Asset Turnover Ratio	IMDX's Dividend Growth
IMDX's Roe	IMDX's Valuation Ratios	IMDX's Financial Strength Ratios	IMDX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-08-12T20:15:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.